Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in infants and young children worldwide. Here we evaluated host demographic and viral factors associated with RSV disease severity in 325 RSV-infected infants under 1 year of age from 3 European countries during 2017-2020. Younger infants had a higher clinical severity (ReSViNET) score and were more likely to require hospitalization, intensive care, respiratory support, and/or mechanical ventilation than older infants (<3 months vs 3 to <6 months and 3 to <6 months vs ≥6 months). Older age (≥6 months vs <3 months), higher viral load, and RSV-A were associated with a greater probability of fever. RSV-A and RSV-B caused similar disease severity and had similar viral dynamics. Infants with a more severe RSV infection, demonstrated by having a higher ReSViNET score, fever, and requiring hospitalization and intensive care, were more likely to have developed subsequent wheezing at 1 year of age.
CLINICAL TRIALS REGISTRATION: NCT03756766.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:226 |
|---|---|
| Enthalten in: |
The Journal of infectious diseases - 226(2022), Suppl 1 vom: 12. Aug., Seite S45-S54 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
McGinley, Joseph P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical Study |
|---|
| Anmerkungen: |
Date Completed 16.08.2022 Date Revised 08.02.2023 published: Print ClinicalTrials.gov: NCT03756766 Citation Status MEDLINE |
|---|
| doi: |
10.1093/infdis/jiac163 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344221121 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344221121 | ||
| 003 | DE-627 | ||
| 005 | 20231226022247.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/infdis/jiac163 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1147.xml |
| 035 | |a (DE-627)NLM344221121 | ||
| 035 | |a (NLM)35902389 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a McGinley, Joseph P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.08.2022 | ||
| 500 | |a Date Revised 08.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a ClinicalTrials.gov: NCT03756766 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in infants and young children worldwide. Here we evaluated host demographic and viral factors associated with RSV disease severity in 325 RSV-infected infants under 1 year of age from 3 European countries during 2017-2020. Younger infants had a higher clinical severity (ReSViNET) score and were more likely to require hospitalization, intensive care, respiratory support, and/or mechanical ventilation than older infants (<3 months vs 3 to <6 months and 3 to <6 months vs ≥6 months). Older age (≥6 months vs <3 months), higher viral load, and RSV-A were associated with a greater probability of fever. RSV-A and RSV-B caused similar disease severity and had similar viral dynamics. Infants with a more severe RSV infection, demonstrated by having a higher ReSViNET score, fever, and requiring hospitalization and intensive care, were more likely to have developed subsequent wheezing at 1 year of age | ||
| 520 | |a CLINICAL TRIALS REGISTRATION: NCT03756766 | ||
| 650 | 4 | |a Clinical Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a disease severity | |
| 650 | 4 | |a respiratory syncytial virus | |
| 650 | 4 | |a subgroup | |
| 650 | 4 | |a viral load | |
| 650 | 4 | |a wheezing | |
| 700 | 1 | |a Lin, Gu Lung |e verfasserin |4 aut | |
| 700 | 1 | |a Öner, Deniz |e verfasserin |4 aut | |
| 700 | 1 | |a Golubchik, Tanya |e verfasserin |4 aut | |
| 700 | 1 | |a O'Connor, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Snape, Matthew D |e verfasserin |4 aut | |
| 700 | 1 | |a Gruselle, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Langedijk, Annefleur C |e verfasserin |4 aut | |
| 700 | 1 | |a Wildenbeest, Joanne |e verfasserin |4 aut | |
| 700 | 1 | |a Openshaw, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Nair, Harish |e verfasserin |4 aut | |
| 700 | 1 | |a Aerssens, Jeroen |e verfasserin |4 aut | |
| 700 | 1 | |a Bont, Louis |e verfasserin |4 aut | |
| 700 | 1 | |a Martinón-Torres, Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Drysdale, Simon B |e verfasserin |4 aut | |
| 700 | 1 | |a Pollard, Andrew J |e verfasserin |4 aut | |
| 700 | 0 | |a RESCEU Investigators |e verfasserin |4 aut | |
| 700 | 1 | |a Nair, Harish |e investigator |4 oth | |
| 700 | 1 | |a Campbell, Harry |e investigator |4 oth | |
| 700 | 1 | |a Cunningham, Steve |e investigator |4 oth | |
| 700 | 1 | |a Bogaert, Debby |e investigator |4 oth | |
| 700 | 1 | |a Beutels, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Bont, Louis |e investigator |4 oth | |
| 700 | 1 | |a Wildenbeest, Joanne |e investigator |4 oth | |
| 700 | 1 | |a Langedijk, Annefleur C |e investigator |4 oth | |
| 700 | 1 | |a Pollard, Andrew |e investigator |4 oth | |
| 700 | 1 | |a Butler, Christopher |e investigator |4 oth | |
| 700 | 1 | |a Snape, Matthew |e investigator |4 oth | |
| 700 | 1 | |a Drysdale, Simon |e investigator |4 oth | |
| 700 | 1 | |a Lin, Gu-Lung |e investigator |4 oth | |
| 700 | 1 | |a O'Connor, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Clutterbuck, Elizabeth |e investigator |4 oth | |
| 700 | 1 | |a McGinley, Joseph |e investigator |4 oth | |
| 700 | 1 | |a Openshaw, Peter |e investigator |4 oth | |
| 700 | 1 | |a Thwaites, Ryan |e investigator |4 oth | |
| 700 | 1 | |a Wiseman, Dexter |e investigator |4 oth | |
| 700 | 1 | |a Martinón-Torres, Federico |e investigator |4 oth | |
| 700 | 1 | |a Gómez-Carballa, Alberto |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez-Tenreiro, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Rivero-Calle, Irene |e investigator |4 oth | |
| 700 | 1 | |a Dacosta-Urbieta, Ana |e investigator |4 oth | |
| 700 | 1 | |a Heikkinen, Terho |e investigator |4 oth | |
| 700 | 1 | |a Meijer, Adam |e investigator |4 oth | |
| 700 | 1 | |a Fischer, Thea K |e investigator |4 oth | |
| 700 | 1 | |a van den Berge, Maarten |e investigator |4 oth | |
| 700 | 1 | |a Giaquinto, Carlo |e investigator |4 oth | |
| 700 | 1 | |a Abram, Michael |e investigator |4 oth | |
| 700 | 1 | |a Myint, Tin Tin |e investigator |4 oth | |
| 700 | 1 | |a Gruselle, Olivier |e investigator |4 oth | |
| 700 | 1 | |a Rizkalla, Bishoy |e investigator |4 oth | |
| 700 | 1 | |a Vernhes, Charlotte |e investigator |4 oth | |
| 700 | 1 | |a Gallichan, Scott |e investigator |4 oth | |
| 700 | 1 | |a Aerssens, Jeroen |e investigator |4 oth | |
| 700 | 1 | |a Öner, Deniz |e investigator |4 oth | |
| 700 | 1 | |a Kumar, Veena |e investigator |4 oth | |
| 700 | 1 | |a Molero, Eva |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 226(2022), Suppl 1 vom: 12. Aug., Seite S45-S54 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
| 773 | 1 | 8 | |g volume:226 |g year:2022 |g number:Suppl 1 |g day:12 |g month:08 |g pages:S45-S54 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiac163 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 226 |j 2022 |e Suppl 1 |b 12 |c 08 |h S45-S54 | ||